iRhythm Holdings, Inc.(IRTC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,911 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
IRTC Stock Analysis & AI Quality Score
AI stock analysis and institutional research for iRhythm Holdings, Inc. (IRTC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores IRTC at 41.1/100 on a 32-signal composite quality model, placing it at rank #1,911 of 2,879 stocks — the bottom half of the AI-ranked universe. IRTC scores in the top quartile across revenue growth (82.6). Areas of concern include balance sheet strength (22.1) and free cash flow (29.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 15.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), iRhythm Holdings, Inc. reports quarterly revenue of $199.4M, net income of $-13.9M, an operating margin of -8.1%. Top institutional holders of IRTC by reported 13-F value include BlackRock,, VANGUARD PORTFOLIO MANAGEMENT, RTW INVESTMENTS,, based on the most recent SEC filings. IRTC trades on the Nasdaq exchange and files with the SEC under CIK 1388658. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IRTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for iRhythm Holdings, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$199.4M
Net Income
Q1 2026
$-13.9M
Free Cash Flow
Q1 2026
$-33.1M
Operating Margin
Q1 2026
-8.1%
Get alerted when IRTC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for iRhythm Holdings, Inc. including:
Top Institutional Holders of IRTC
BlackRock, Inc.
$323.6M2,741,505 shVANGUARD PORTFOLIO MANAGEMENT LLC
$212.0M1,796,372 shRTW INVESTMENTS, LP
$196.9M1,668,500 shMILLENNIUM MANAGEMENT LLC
$189.8M1,608,014 shArtisan Partners Limited Partnership
$171.2M1,450,907 shVANGUARD CAPITAL MANAGEMENT LLC
$170.6M1,445,710 shFMR LLC
$160.7M1,361,919 shHolocene Advisors, LP
$147.4M1,248,658 shUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME
$123.6M1,047,452 shGEODE CAPITAL MANAGEMENT, LLC
$96.5M817,110 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $323.6M | 2,741,505 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $212.0M | 1,796,372 |
| RTW INVESTMENTS, LP | $196.9M | 1,668,500 |
| MILLENNIUM MANAGEMENT LLC | $189.8M | 1,608,014 |
| Artisan Partners Limited Partnership | $171.2M | 1,450,907 |
| VANGUARD CAPITAL MANAGEMENT LLC | $170.6M | 1,445,710 |
| FMR LLC | $160.7M | 1,361,919 |
| Holocene Advisors, LP | $147.4M | 1,248,658 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME | $123.6M | 1,047,452 |
| GEODE CAPITAL MANAGEMENT, LLC | $96.5M | 817,110 |
More Healthcare Companies
View all Healthcare →Put IRTC on your watchlist
Track score changes the day iRhythm Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is IRTC a good stock to buy?
13F Pro's AI-powered analysis of iRhythm Holdings, Inc. (IRTC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IRTC are available on the IRTC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own IRTC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IRTC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of iRhythm Holdings, Inc.'s investment landscape.